Concepedia

652O Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)

Kathryn C. Arbour, Salman R. Punekar, Ignacio Garrido‐Laguna, David S. Hong, Brian M. Wolpin, Meredith S. Pelster, M. Barve, Alexander Starodub, D. Sommerhalder, Sam S. Chang,

Annals of Oncology · 2023 · 115 citations · 1 references

DOIFull text

Open access

Concepts

References

1

652O Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)

Kathryn C. Arbour, Salman R. Punekar, Ignacio Garrido‐Laguna et al. · Annals of Oncology · 2023 · 115 citations · Full text

, , +15